Skip Navigation
Site Search
 
Search this site only
Search Heartland.org

Research

  • Date
  • Topic
  • Type
View  10  |  20  |  40
Health Care
May 20, 2019
By Sen. Ted Cruz (R-TX), Sen. Mike Braun (R-IN), Rand Paul (R-KY), Sen. Mike Lee (R-UT)
"Similar to the HIV/AIDS crisis, promising, potentially life-saving drugs for these diseases are mired in Phases II and III of the drug-approval process."
May 20, 2019
Annual trustee report as required by the Social Security Act on the financial status of the Hospital Insurance Trust Fun and the Supplementary Medical Insurance Trust Fund.
May 17, 2019
By The Physicians Advocacy Institute
Report by the Physician Advocacy Institute on hospital acquisition of private physician practices.
May 15, 2019
By Matthew Glans
In this Research & Commentary, Matthew Glans examines reference pricing and how it could be a valuable tool for states seeking to reduce skyrocketing health care costs while maintaining a high-quality standard of care.
May 10, 2019
By Christina Herrin
Legislation would expand Right To Try, but doesn't go far enough.
May 10, 2019
By Matthew Glans
In this Research & Commentary, Matthew Glans examines a bill in Rhode Island that would allow physician assistants to care for patients without being directly supervised by medical doctors, dramatically improving their ability to provide care.
May 10, 2019
By Matthew Glans
In this Research & Commentary, Matthew Glans examines a bill that would shift thousands of Alaskans covered under Alaska’s expanded Medicaid program onto subsidized private insurance plans.
May 7, 2019
Stakeholders urge FDA to change course on new guidelines to require suffix on biosimilar drugs.
May 6, 2019
A number of states under pressure to expand their Medicaid programs are instead finding opportunities to customize their programs through federal waivers.
May 6, 2019
It took two attempts, but the Arkansas House of Representatives passed a Medicaid funding bill after rejecting it days after U.S. District Judge James Boasberg blocked the state, along with Kentucky, from implementing a work requirement for able-bodied Me
May 3, 2019
By AnneMarie Schieber
In May, the Trump administration will be wrapping up comment periods for two consumer-oriented initiatives reforming the way health insurance operates with providers and across state lines.
May 2, 2019
By Matthew Glans
In this Research & Commentary, Matthew Glans discusses the rapidly rising cost of Virginia's Medicaid program and how Medicaid expansion is exacerbating the problem.
May 2, 2019
Seven groups express concern over FDA's newly released guidelines onbio similar naming
May 1, 2019
By Kenneth Artz
Texas Attorney General Ken Paxton (R) filed a brief in a lawsuit brought by Planned Parenthood, asking the U.S. Fifth Circuit Court of Appeals to deny lawsuits by individual Medicaid recipients intended to force taxpayer funding for abortions.
May 1, 2019
By Kenneth Artz
Eight states are asking a court to strike an Obamacare rule they say violates their authority to protect the judgment and conscience rights of medical professionals.
May 1, 2019
By Ashley Herzog
Florida lawmakers are addressing what the state’s house speaker has called the “hospital-industrial complex” with several bills aimed at increasing competition and reducing government’s role in health care.
May 1, 2019
The Centers for Medicare and Medicaid Services (CMS) initiated a 60-day public comment period March 11 on possible federal reform that would allow health insurance companies to sell plans across state lines.
May 1, 2019
By Ashley Bateman
Lawmakers in Utah rolled out a “partial” Medicaid expansion program April 1 after the Centers for Medicare and Medicaid Services (CMS) granted approval to enroll people making under $12,500 a year, less than the $17,200 limit voters approved in 2018.
May 1, 2019
By Ashley Bateman
Nurse practitioners (NP) in states across the country are asking lawmakers to relax onerous licensing regulations so they can help fill an anticipated shortage of primary care doctors.
April 30, 2019
By Edward Hudgins
This Policy Brief argues an FTCM approach, by collecting real-world data on the effects of new drugs, would provide more patients with access to potentially life-saving drugs, and it would do so faster and more efficiently than the current FDA system.